Crossmark

Development of reverse phase high-performance liquid chromatographic method for the estimation of HIV non-nucleoside reverse transcriptase inhibitor drug efavirenz in the rat brain

Crossref DOI link: https://doi.org/10.1186/s43094-020-00158-3

Published Online: 2021-01-07

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kakad, Smita Prakash http://orcid.org/0000-0002-9218-9810
Kshirsagar, Sanjay Jayprakash
License Information

Text and Data Mining valid from 2021-01-07

Version of Record valid from 2021-01-07
More Information

Article History

Received: 1 October 2020

Accepted: 15 December 2020

First Online: 7 January 2021

Ethics approval and consent to participate

: The study was approved by the Institutional Animal Ethical Committee of METs Institute of Pharmacy, Nashik (Approval number MET-IOP-IAEC/2019-20/02), India.

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below